Chengdu Bright Eye Hospital Co. Ltd. Capital Reinvestment Ratio

Latest as of December 2025: 0.42x

Chengdu Bright Eye Hospital Co. Ltd. capital reinvestment ratio. Chengdu Bright Eye Hospital Co. Ltd. (301239) has a Capital Reinvestment Ratio of 0.42x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥544.86 Million) in capital expenditures (CN¥226.41 Million). Check Chengdu Bright Eye Hospital Co. Ltd. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.42x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥544.86 Million
CNY

Capital Expenditures

CN¥226.41 Million
CNY

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of Chengdu Bright Eye Hospital Co. Ltd. (2019–2025)

Capital reinvestment ratio of Chengdu Bright Eye Hospital Co. Ltd. from 2019 to 2025. This chart tracks Chengdu Bright Eye Hospital Co. Ltd.'s Capital Reinvestment Ratio across 7 annual periods. Also explore net asset growth rate of Chengdu Bright Eye Hospital Co. Ltd. to track the company's year-over-year net asset growth rate.

Chengdu Bright Eye Hospital Co. Ltd. Capital Reinvestment Ratio by Year (2019–2025)

Chengdu Bright Eye Hospital Co. Ltd. capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see 301239 operating cash flow.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.42x CN¥544.86 Million CN¥226.41 Million ▼ -70.7%
2024 1.42x CN¥382.43 Million CN¥542.86 Million ▲ +39.1%
2023 1.02x CN¥614.46 Million CN¥626.87 Million ▼ -0.7%
2022 1.03x CN¥319.30 Million CN¥327.99 Million ▲ +44.9%
2021 0.71x CN¥359.42 Million CN¥254.80 Million ▲ +10.0%
2020 0.64x CN¥227.51 Million CN¥146.60 Million ▼ -72.5%
2019 2.35x CN¥104.83 Million CN¥245.97 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow